Cytogenetic aberrations and the development of uterine leiomyomata

被引:20
作者
El-Gharib, Mohamed N. [1 ]
Elsobky, Ezzat S. [2 ]
机构
[1] Tanta Univ, Fac Med, Dept Obstet & Gynecol, Tanta, Egypt
[2] Ain Shams Univ, Genet Unit, Cairo, Egypt
关键词
benign tumours of the uterus; chromosomal study; fibroids; fibroid size; leiomyoma; NONCANCER DISEASE INCIDENCE; ATOMIC-BOMB SURVIVORS; ABNORMALITIES; CHROMOSOME-7; REARRANGEMENT; DELETION; MYOMAS; DEL(7);
D O I
10.1111/j.1447-0756.2009.01099.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study was conducted to define the cytogenetically critical regions of uterine leiomyomata, hoping to demonstrate the presence of possible genes involved in their evolution. It was carried out on 25 randomly selected uterine leiomyoma specimens obtained from 16 patients during hysterectomy or myomectomy operations. Successful tissue culture and karyotyping were performed in 19 specimens. There was no correlation between patient age, gravidity, or presenting symptom and the presence of chromosomal abnormality. A significant correlation was found between short culture turnaround time and the occurrence of chromosomal abnormality. Abnormal clonal karyotypes were present in 6 specimens, non-clonal abnormalities in 4 specimens and normal karyotypes were found in 9 specimens. Myomas with cross section > 4 cm showed an increased incidence of abnormal karyotypes and a statistically significant higher incidence of clonal abnormalities. On the other hand, submucous myomas presented fewer clonal abnormalities than did intramural or subserosal myomas. Clonal chromosomal abnormalities involved 5 different chromosomes (2, 7, 8, 12, 22), which indicate genetic heterogeneity of such benign tumors and the need of molecular cytogenetic studies or molecular studies to characterize possible candidate genes at specific chromosomal breakpoints.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 39 条
[1]   Clinical significance of cytogenetic abnormalities in uterine myomas [J].
Brosens, I ;
Deprest, J ;
Dal Cin, P ;
Van den Bergh, H .
FERTILITY AND STERILITY, 1998, 69 (02) :232-235
[2]  
DOMENIGHETTI G, 1988, LANCET, V2, P1470
[3]  
FUJII S, 2004, P 18 WORLD C FERT ST, V1266, P183
[4]   ONTOGENY OF THE ESTROGEN-RECEPTOR IN THE HUMAN FETAL UTERUS [J].
GLATSTEIN, IZ ;
YEH, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :958-964
[5]  
HEIM S, 1998, CANCER GENET CYTOGEN, V1, P13
[6]   HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality [J].
Hennig, Y ;
Rogalla, P ;
Wanschura, S ;
Frey, G ;
Deichert, U ;
Bartnitzke, S ;
Bullerdiek, J .
CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) :129-133
[7]  
HENNING Y, 1999, MOL HUM REPROD, V12, P1150
[8]   SUBGROUPS OF UTERINE LEIOMYOMAS BASED ON CYTOGENETIC ANALYSIS [J].
HU, J ;
SURTI, U .
HUMAN PATHOLOGY, 1991, 22 (10) :1009-1016
[9]   MOLECULAR AND CYTOGENETIC ANALYSIS OF CHROMOSOME-7 IN UTERINE LEIOMYOMAS [J].
ISHWAD, CS ;
FERRELL, RE ;
DAVARE, J ;
MELONI, AM ;
SANDBERG, AA ;
SURTI, U .
GENES CHROMOSOMES & CANCER, 1995, 14 (01) :51-55
[10]   CYTOGENETIC FINDINGS IN UTERINE EPITHELIOID LEIOMYOMAS [J].
KARAISKOS, C ;
PANDIS, N ;
BARDI, G ;
SFIKAS, K ;
TSERKEZOGLOU, A ;
FOTIOU, S ;
HEIM, S .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (02) :103-106